Greetings fellow PIQants.
I contacted the company to get some clarification on the 500 cohort validation study requested by our potential (and apparently keen) commercialisation partner. I was particularly concerned about the timeframe to do another validation study.
The Company said that it does not expect there to be an extended timeframe for the reporting of results, as the patient cohort was taken from the Fremantle Diabetes Study, a large ongoing study, which means there is no lead time in trial patient recruitment and then time-in-the-trial – the patient cohort is already readily available.
I also queried them on the impact of the new development program for PromarkerD IVD test kit and its impact/relationship on current partnering discussions. They indicated that it's completely complementary to the Company’s ongoing partnering and licensing discussions. It provides multiple commercialisation pathways for PromarkerD, and in no way impacts on the multiple, positive ongoing commercialisation discussions.
I agree with @sbarett regarding the potential for this tightly held little gem to rapidly appreciate once the ink dries on any commercialisation deal and I get the sense that it may not be too far away. The smart money is accumulating at a heavy discount as patience thins.
As always, DYOR.
- Forums
- ASX - By Stock
- News: PIQ Proteomics International Laboratories says co remains in discussions for the...
Greetings fellow PIQants. I contacted the company to get some...
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
Add PIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
66.0¢ |
Change
-0.035(5.04%) |
Mkt cap ! $87.11M |
Open | High | Low | Value | Volume |
68.5¢ | 68.5¢ | 65.5¢ | $71.36K | 107.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 10373 | 65.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
66.5¢ | 4460 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6406 | 0.660 |
3 | 10373 | 0.655 |
6 | 34139 | 0.650 |
3 | 18388 | 0.645 |
1 | 1366 | 0.640 |
Price($) | Vol. | No. |
---|---|---|
0.665 | 4460 | 1 |
0.670 | 19076 | 4 |
0.675 | 1366 | 1 |
0.680 | 1381 | 2 |
0.685 | 102700 | 2 |
Last trade - 13.22pm 04/10/2024 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |